One of the important treatment options to consider for patients who suffer from major depressive disorder—NOT for all patients, but for some of them—is esketamine nasal spray (Spravato®).
But most clinicians don’t themselves provide treatment with esketamine nasal spray and need to know exactly WHOM to refer for this treatment, WHERE to refer, and HOW to refer, that is, what exactly do referring clinicians need to do.
In this article, we’ll provide you with everything you need to know about these issues.
Here are links to our other articles about esketamine nasal spray (Spravato®):